相关实验视频

Updated: Jul 3, 2025

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

用化学受体准固体瘤抗原:癌症生物学与合成免疫学相遇

Gabriele J Kembuan¹, Joanna Y Kim¹, Marcela V Maus²

¹Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, USA; Harvard Medical School, Boston, MA, USA; Department of Pathology, Massachusetts General Hospital, Boston, MA, USA.

Trends in cancer

|February 14, 2024

概括

化学抗原受体 (CAR) T细胞疗法在B细胞癌症之外的固体瘤方面显示出前景. 研究正在探索新的点和合成生物学,用于先进的CAR T细胞治疗.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

化学抗原受体 (CAR) T细胞疗法已经彻底改变了B细胞恶性瘤治疗.
目前正在进行重大研究,以适应CAR T细胞治疗固体瘤的方法.
固体瘤标与B细胞抗原不同,包括新抗原和瘤相关抗原 (TAA).

研究的目的:

在癌症生物学和基因调节的背景下,审查固体瘤点抗原.
分析针对固体瘤的CAR T细胞疗法的新兴临床数据.
讨论新型细胞免疫疗法的合成生物学策略.

主要方法:

关于固体瘤向抗原和癌症生物学的文献综述.
对与瘤抗原有关的基因调节的分析.
对实体瘤CAR T细胞疗法的早期临床试验数据的审查.
在细胞免疫疗法中探索合成生物学应用.

主要成果:

多项早期临床试验显示,针对固体瘤的CAR T细胞疗法具有令人鼓舞的疗效.
固体瘤向涉及各种抗原,如新抗原和TAA.
新兴的合成生物学方法正在临床开发中应用.

结论:

卡尔T细胞疗法具有治疗固体瘤的潜力.
了解瘤抗原生物学和基因调控对于有效准至关重要.
合成生物学为下一代CAR T细胞疗法提供了创新策略.

关键词:

在CAR-T细胞中.针对抗原的向.细胞免疫疗法细胞免疫疗法固体瘤是一个固体瘤.合成生物学合成生物学

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

In Vitro Tumor Cell Rechallenge For Predictive Evaluation of Chimeric Antigen Receptor T Cell Antitumor Function

Published on: February 27, 2019

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.